Versant Ventures in AI answers

Versant Ventures is a global biotechnology-focused venture capital firm with $5.5 billion under management, backing science-driven companies and reporting 50+ IPOs and 50+ M&As since 1999. It operates three Discovery Engines—in-house, multidisciplinary labs that enable the launch of novel biotech companies with academic founders—and maintains 30+ academic partnerships across six locations. Backed by a team with extensive VC, pharma, and biotech experience, Versant partners with researchers and startups to translate scientific discoveries into commercial therapies.